Cargando…

Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature

BACKGROUND: Sarcoma encompasses an uncommon group of cancer and the data is insufficient from Pakistan. We report our four years experience of Sarcoma of soft tissues and bones. METHODS: This cross sectional study was carried out at Aga Khan University Hospital from 2004 to 2008. The patients were d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, Tayyaba Z, Masood, Nehal, Parekh, Asra, Jafri, Rabab Z, Niamatullah, Syed N, Zaidi, Adnan A, Umer, Masood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112416/
https://www.ncbi.nlm.nih.gov/pubmed/21586114
http://dx.doi.org/10.1186/1477-7819-9-51
_version_ 1782205743179497472
author Ansari, Tayyaba Z
Masood, Nehal
Parekh, Asra
Jafri, Rabab Z
Niamatullah, Syed N
Zaidi, Adnan A
Umer, Masood
author_facet Ansari, Tayyaba Z
Masood, Nehal
Parekh, Asra
Jafri, Rabab Z
Niamatullah, Syed N
Zaidi, Adnan A
Umer, Masood
author_sort Ansari, Tayyaba Z
collection PubMed
description BACKGROUND: Sarcoma encompasses an uncommon group of cancer and the data is insufficient from Pakistan. We report our four years experience of Sarcoma of soft tissues and bones. METHODS: This cross sectional study was carried out at Aga Khan University Hospital from 2004 to 2008. The patients were divided into two groups from the outset i.e. initially diagnosed and relapsed group and separate sub group analysis was conducted. RESULTS: Out of 93 newly diagnosed patients, 58 belonged to bone sarcoma and 35 to soft tissue sarcoma group. While for relapsed patients, 5 had soft tissue sarcoma and 9 had bone sarcoma. Mean age was 32.5 years. At presentation, approximately two third patients had localised disease while remaining one third had metastatic disease. The Kaplan Meier estimate of median recurrence free survival was 25 months, 35 months, and 44 months for Osteogenic sarcoma, Ewing's sarcoma and Chondrosarcoma respectively. For Leiomyosarcoma and Synovial sarcoma, it was 20 and 19 months respectively. The grade of the tumour (p = 0.02) and surgical margin status (p = 0.001) were statistically significant for determination of relapse of disease. CONCLUSION: The median recurrence free survival of patients in our study was comparable to the reported literature but with significant lost to follow rate. Further large-scale, multi centre studies are needed to have a more comprehensive understanding of this heterogeneous disease in our population.
format Online
Article
Text
id pubmed-3112416
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31124162011-06-12 Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature Ansari, Tayyaba Z Masood, Nehal Parekh, Asra Jafri, Rabab Z Niamatullah, Syed N Zaidi, Adnan A Umer, Masood World J Surg Oncol Research BACKGROUND: Sarcoma encompasses an uncommon group of cancer and the data is insufficient from Pakistan. We report our four years experience of Sarcoma of soft tissues and bones. METHODS: This cross sectional study was carried out at Aga Khan University Hospital from 2004 to 2008. The patients were divided into two groups from the outset i.e. initially diagnosed and relapsed group and separate sub group analysis was conducted. RESULTS: Out of 93 newly diagnosed patients, 58 belonged to bone sarcoma and 35 to soft tissue sarcoma group. While for relapsed patients, 5 had soft tissue sarcoma and 9 had bone sarcoma. Mean age was 32.5 years. At presentation, approximately two third patients had localised disease while remaining one third had metastatic disease. The Kaplan Meier estimate of median recurrence free survival was 25 months, 35 months, and 44 months for Osteogenic sarcoma, Ewing's sarcoma and Chondrosarcoma respectively. For Leiomyosarcoma and Synovial sarcoma, it was 20 and 19 months respectively. The grade of the tumour (p = 0.02) and surgical margin status (p = 0.001) were statistically significant for determination of relapse of disease. CONCLUSION: The median recurrence free survival of patients in our study was comparable to the reported literature but with significant lost to follow rate. Further large-scale, multi centre studies are needed to have a more comprehensive understanding of this heterogeneous disease in our population. BioMed Central 2011-05-17 /pmc/articles/PMC3112416/ /pubmed/21586114 http://dx.doi.org/10.1186/1477-7819-9-51 Text en Copyright ©2011 Ansari et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ansari, Tayyaba Z
Masood, Nehal
Parekh, Asra
Jafri, Rabab Z
Niamatullah, Syed N
Zaidi, Adnan A
Umer, Masood
Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title_full Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title_fullStr Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title_full_unstemmed Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title_short Four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
title_sort four year experience of sarcoma of soft tissues and bones in a tertiary care hospital and review of literature
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112416/
https://www.ncbi.nlm.nih.gov/pubmed/21586114
http://dx.doi.org/10.1186/1477-7819-9-51
work_keys_str_mv AT ansaritayyabaz fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT masoodnehal fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT parekhasra fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT jafrirababz fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT niamatullahsyedn fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT zaidiadnana fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature
AT umermasood fouryearexperienceofsarcomaofsofttissuesandbonesinatertiarycarehospitalandreviewofliterature